Regulon

Regulon: R-192

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
722.32844174Pr-7Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
221 ENSG00000006534 ALDH3B1 P43353
920 ENSG00000010610 CD4 P01730
7454 ENSG00000015285 WAS P42768
864 ENSG00000020633 RUNX3 Q13761
7133 ENSG00000028137 TNFRSF1B P20333
3937 ENSG00000043462 LCP2 Q13094
2769 ENSG00000060558 GNA15 K7EP74
51167 ENSG00000065615 CYB5R4 Q7L1T6
6688 ENSG00000066336 SPI1 P17947
11320 ENSG00000071073 MGAT4A Q9UM21
64778 ENSG00000075420 FNDC3B Q53EP0
55843 ENSG00000075884 ARHGAP15 Q53QZ3
8569 ENSG00000079277 MKNK1 Q9BUB5
5996 ENSG00000090104 RGS1 Q08116
4069 ENSG00000090382 LYZ P61626
54918 ENSG00000091317 CMTM6 Q9NX76
22861 ENSG00000091592 NLRP1 Q9C000
4627 ENSG00000100345 MYH9 P35579
1439 ENSG00000100368 CSF2RB P32927
1522 ENSG00000101160 CTSZ Q9UBR2
3055 ENSG00000101336 HCK P08631
51311 ENSG00000101916 TLR8 Q9NR97
11151 ENSG00000102879 CORO1A P31146
50615 ENSG00000103522 IL21R Q9HBE5
57817 ENSG00000105697 HAMP P81172
944 ENSG00000106952 TNFSF8 Q52M88
2022 ENSG00000106991 ENG P17813
9404 ENSG00000110031 LPXN O60711
3587 ENSG00000110324 IL10RA Q13651
51411 ENSG00000110934 BIN2 Q9UBW5
10019 ENSG00000111252 SH2B3 Q9UQQ2
1389 ENSG00000111269 CREBL2 O60519
5777 ENSG00000111679 PTPN6 P29350
9450 ENSG00000112799 LY86 O95711
55819 ENSG00000113269 RNF130 Q86XS8
942 ENSG00000114013 CD86 P42081
7867 ENSG00000114738 MAPKAPK3 Q16644
2335 ENSG00000115414 FN1 P02751
56944 ENSG00000116774 OLFML3 Q9NRN5
4053 ENSG00000119681 LTBP2 Q14767
113 ENSG00000121281 ADCY7 P51828
2162 ENSG00000124491 F13A1 P00488
1236 ENSG00000126353 CCR7 P32248
4245 ENSG00000131446 MGAT1 P26572
4814 ENSG00000131669 NINJ1 Q92982
3936 ENSG00000136167 LCP1 P13796
27141 ENSG00000136305 CIDEB Q9UHD4
1318 ENSG00000136867 SLC31A2 O15432
55589 ENSG00000138756 BMP2K Q9NSY1
11010 ENSG00000139278 GLIPR1 B4E3S5
8477 ENSG00000140030 GPR65 Q8IYL9
6518 ENSG00000142583 SLC2A5 P22732
963 ENSG00000143119 CD53 P19397
10184 ENSG00000145685 LHFPL2 Q6ZUX7
23643 ENSG00000154589 LY96 Q9Y6Y9
2207 ENSG00000158869 FCER1G P30273
3689 ENSG00000160255 ITGB2 D3DSM0
3570 ENSG00000160712 IL6R P08887
1234 ENSG00000160791 CCR5 P51681
3678 ENSG00000161638 ITGA5 P08648
5966 ENSG00000162924 REL Q04864
7048 ENSG00000163513 TGFBR2 A3QNQ0
11314 ENSG00000167851 CD300A Q9UGN4
3965 ENSG00000168961 LGALS9 O00182
3684 ENSG00000169896 ITGAM P11215
2 ENSG00000175899 A2M P01023
391 ENSG00000177105 RHOG Q6ICQ8
2124 ENSG00000185862 EVI2B P34910
4668 ENSG00000198951 NAGA P17050
4067 ENSG00000254087 LYN P07948
240 ENSG00000275565 ALOX5 P09917
10859 ENSG00000277807 LILRB1 Q8NHL6

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
LY-2787106HAMPAntibodyINHIBITORHepcidin inhibitor10
SARGRAMOSTIMCSF2RBProteinAGONISTGranulocyte-macrophage colony-stimulating factor receptor agonist42
ATN-161ITGB3ProteinANTAGONISTIntegrin alpha-5/beta-1 antagonist20
AME-133VITGB2AntibodyINHIBITORIntegrin beta-2 inhibitor20
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
ABATACEPTCD80ProteinINHIBITORT-lymphocyte activation antigen CD80 inhibitor40
L19IL2FN1AntibodyBINDING AGENTFibronectin binding agent30
AS-1409FN1AntibodyBINDING AGENTFibronectin binding agent10
CCR5MAB004CCR5AntibodyINHIBITORC-C chemokine receptor type 5 inhibitor10
VRC-01LSCD4UnknownBINDING AGENTT-cell surface antigen CD4 binding agent20
VICRIVIROCCCR5Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist30
VOBARILIZUMABIL6RAntibodyINHIBITORInterleukin-6 receptor alpha subunit inhibitor20
CAROTUXIMABENGAntibodyINHIBITOREndoglin inhibitor32
L19TNFAFN1AntibodyBINDING AGENTFibronectin binding agent20
APLAVIROCCCR5Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist30
MARAVIROCCCR5Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist40
EFALIZUMABITGALAntibodyINHIBITORIntegrin alpha-L/beta-2 (LFA-1) inhibitor40
BOSUTINIBABL1Small moleculeINHIBITORBcr/Abl fusion protein42
BAFETINIBLYNSmall moleculeINHIBITORTyrosine-protein kinase ABL inhibitor20
TOCILIZUMABIL6RAntibodyINHIBITORInterleukin-6 receptor alpha subunit inhibitor42
LERONLIMABCCR5AntibodyANTAGONISTC-C chemokine receptor type 5 antagonist30
ILORASERTIBPDGFRBSmall moleculeINHIBITORSerine/threonine-protein kinase Aurora inhibitor20
JNJ-26483327ERBB2Small moleculeINHIBITORTyrosine-protein kinase FYN inhibitor10
L19SIP 131IFN1AntibodyOTHERFibronectin other20
HGS-1025CCR5AntibodyINHIBITORC-C chemokine receptor type 5 inhibitor10
PF-04605412ITGA5AntibodyINHIBITORFibronectin receptor alpha inhibitor10
SARILUMABIL6RAntibodyANTAGONISTInterleukin-6 receptor alpha subunit antagonist40
CENICRIVIROCCCR2Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist30
APLAVIROC HYDROCHLORIDECCR5Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist30
BELATACEPTCD80ProteinINHIBITORT-lymphocyte activation antigen CD80 inhibitor40
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
SATRALIZUMABIL6RAntibodyANTAGONISTIL6Ralpha/GP130 antagonist40
SELGANTOLIMODTLR8Small moleculeAGONISTToll-like receptor 8 agonist20
TOLIMIDONELYNSmall moleculePOSITIVE ALLOSTERIC MODULATORTyrosine-protein kinase Lyn positive allosteric modulator20
MAVRILIMUMABCSF2RBAntibodyANTAGONISTGranulocyte-macrophage colony-stimulating factor receptor antagonist20
MOTOLIMODTLR8Small moleculeAGONISTToll-like receptor 8 agonist20
TREGALIZUMABCD4AntibodyAGONISTT-cell surface antigen CD4 agonist20
ERITORAN TETRASODIUMTLR4Small moleculeANTAGONISTToll-like receptor 4/MD-2 antagonist30
TOMIVOSERTIBMKNK2Small moleculeINHIBITORMAP kinase-interacting serine/threonine-protein kinase 1/2 inhibitor20
BMS-813160CCR5Small moleculeANTAGONISTC-C chemokine receptor type 2 antagonist20
PF-04634817CCR5Small moleculeANTAGONISTC-C chemokine receptor type 2 antagonist20
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
INCB-9471CCR5Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist20
VICRIVIROC MALEATECCR5Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist30
LIFITEGRASTITGALSmall moleculeANTAGONISTIntegrin alpha-L/beta-2 (LFA-1) antagonist40
PF-232798CCR5Small moleculeINHIBITORC-C chemokine receptor type 5 inhibitor20
ZANOLIMUMABCD4AntibodyOTHERT-cell surface antigen CD4 other30
TELRATOLIMODTLR8Small moleculeAGONISTToll-like receptor 8 agonist10
AZD5672CCR5Small moleculeANTAGONISTC-C chemokine receptor type 5 antagonist20
IBALIZUMABCD4AntibodyINHIBITORT-cell surface antigen CD4 inhibitor40
OCRIPLASMINLAMA2EnzymePROTEOLYTIC ENZYMEFibronectin proteolytic enzyme40
UB-421CD4UnknownINHIBITORT-cell surface antigen CD4 inhibitor30
ERITORANTLR4Small moleculeANTAGONISTToll-like receptor 4/MD-2 antagonist30
VOLOCIXIMABITGB1AntibodyANTAGONISTIntegrin alpha-5/beta-1 antagonist30
LEVILIMABIL6RAntibodyINHIBITORInterleukin-6 receptor alpha subunit inhibitor30
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-192

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-01138ZNF292down-regulatesRUNX3activatesR-192113Drugs (56)
CMF-01992PCDH9down-regulatesRUNX3activatesR-192115Drugs (56)
CMF-09972FBN1down-regulatesRUNX3activatesR-192111Drugs (56)
CMF-11148MYO18Adown-regulatesRUNX3activatesR-192112Drugs (56)
CMF-13859ADAMTS8down-regulatesRUNX3activatesR-192112Drugs (56)
CMF-16760CPNE8up-regulatesRUNX3activatesR-192112Drugs (56)
CMF-18054PRPF40Bdown-regulatesRUNX3activatesR-192116Drugs (56)
CMF-19549NF1up-regulatesRUNX3activatesR-1921110Drugs (56)
CMF-22176PDGFRAdown-regulatesRUNX3activatesR-192112Drugs (56)
CMF-30666SALL4down-regulatesRUNX3activatesR-192113Drugs (56)
CMF-33891SKAP2down-regulateshsa-mir-641repressesR-19286Drugs (56)
CMF-33918SDPRdown-regulateshsa-mir-30brepressesR-19293Drugs (56)
CMF-34856NEBdown-regulateshsa-mir-30drepressesR-192295Drugs (56)
CMF-34861NEBdown-regulateshsa-mir-301repressesR-192377Drugs (56)
CMF-35047FGFR3down-regulateshsa-mir-454-3prepressesR-1923129Drugs (56)
CMF-35078FGFR3down-regulateshsa-mir-20brepressesR-1924426Drugs (56)
CMF-35188SCNN1Gup-regulateshsa-mir-106brepressesR-1922113Drugs (56)
CMF-35956AHNAK2up-regulateshsa-mir-361repressesR-192146Drugs (56)
CMF-35969AHNAK2up-regulateshsa-mir-106brepressesR-1922116Drugs (56)
CMF-35991AHNAK2up-regulateshsa-mir-93repressesR-1924426Drugs (56)
CMF-36019AHNAK2up-regulateshsa-mir-20brepressesR-1924426Drugs (56)
CMF-36143TNK2up-regulateshsa-mir-17-3prepressesR-1925240Drugs (56)
CMF-36374DIAPH2up-regulateshsa-mir-30brepressesR-19292Drugs (56)
CMF-36685ATP8A2up-regulateshsa-mir-454-3prepressesR-1923127Drugs (56)
CMF-36719ATP8A2up-regulateshsa-mir-17-3prepressesR-1925240Drugs (56)
CMF-36754ATP8A2up-regulateshsa-mir-93repressesR-1924432Drugs (56)
CMF-36788ATP8A2up-regulateshsa-mir-20brepressesR-1924431Drugs (56)
CMF-37165CYP4F22down-regulateshsa-mir-7repressesR-1921817Drugs (56)
CMF-37181CYP4F22down-regulateshsa-mir-30drepressesR-1922918Drugs (56)
CMF-37686ADAMTS8up-regulateshsa-mir-17-3prepressesR-1925240Drugs (56)
CMF-37869PRKCDup-regulateshsa-mir-641repressesR-19286Drugs (56)
CMF-37953COL6A2down-regulateshsa-mir-17-3prepressesR-1925217Drugs (56)
CMF-38082OR51F1up-regulateshsa-mir-106brepressesR-1922117Drugs (56)
CMF-38101OR51F1up-regulateshsa-mir-93repressesR-1924435Drugs (56)
CMF-38317ZNF845up-regulateshsa-mir-454-3prepressesR-1923127Drugs (56)
CMF-38344ZNF845up-regulateshsa-mir-641repressesR-19285Drugs (56)
CMF-38404KCNB2down-regulateshsa-mir-30drepressesR-192295Drugs (56)
CMF-38409KCNB2down-regulateshsa-mir-361repressesR-192144Drugs (56)
CMF-38413KCNB2down-regulateshsa-mir-301repressesR-192375Drugs (56)
CMF-38421KCNB2down-regulateshsa-mir-106brepressesR-1922115Drugs (56)
CMF-38440KCNB2down-regulateshsa-mir-17-3prepressesR-1925236Drugs (56)
CMF-38473KCNB2down-regulateshsa-mir-93repressesR-1924427Drugs (56)
CMF-38563CPNE8down-regulateshsa-mir-17-3prepressesR-1925228Drugs (56)
CMF-38587CPNE8down-regulateshsa-mir-93repressesR-1924420Drugs (56)
CMF-39131DNMBPdown-regulateshsa-mir-17-3prepressesR-1925235Drugs (56)
CMF-39222ZNF569up-regulateshsa-mir-7repressesR-192183Drugs (56)
CMF-39331INPP5Jup-regulateshsa-mir-641repressesR-19285Drugs (56)
CMF-39554NF1down-regulateshsa-mir-106brepressesR-1922120Drugs (56)
CMF-39622NF1down-regulateshsa-mir-93repressesR-1924431Drugs (56)
CMF-39712NF1down-regulateshsa-mir-20brepressesR-1924431Drugs (56)
CMF-39741RPSAP58down-regulateshsa-mir-301repressesR-1923712Drugs (56)
CMF-39761RPSAP58down-regulateshsa-mir-17-3prepressesR-1925240Drugs (56)
CMF-39792RPSAP58down-regulateshsa-mir-641repressesR-19287Drugs (56)
CMF-39818UGT2B4down-regulateshsa-mir-149repressesR-1925135Drugs (56)
CMF-39898TDRD9down-regulateshsa-mir-30drepressesR-1922916Drugs (56)
CMF-39913TDRD9down-regulateshsa-mir-361repressesR-192149Drugs (56)
CMF-39925TDRD9down-regulateshsa-mir-106brepressesR-1922121Drugs (56)
CMF-39953TDRD9down-regulateshsa-mir-17-3prepressesR-1925242Drugs (56)
CMF-40133STAB2up-regulateshsa-mir-106brepressesR-192218Drugs (56)
CMF-40306MUC17down-regulateshsa-mir-30brepressesR-19299Drugs (56)
CMF-41265TP53up-regulateshsa-mir-301repressesR-1923728Drugs (56)
CMF-41325TP53up-regulateshsa-mir-17-3prepressesR-1925252Drugs (56)
CMF-41373TP53up-regulateshsa-mir-93repressesR-1924444Drugs (56)
CMF-41534TP53up-regulateshsa-mir-20brepressesR-1924444Drugs (56)
CMF-42182NAALADL1down-regulateshsa-mir-301repressesR-1923710Drugs (56)
CMF-42349SDK1down-regulateshsa-mir-7repressesR-1921814Drugs (56)
CMF-42386KRTAP20-2down-regulateshsa-mir-7repressesR-1921815Drugs (56)
CMF-42417ANKRD36down-regulateshsa-mir-30drepressesR-1922911Drugs (56)
CMF-42437ANKRD36down-regulateshsa-mir-641repressesR-19286Drugs (56)
CMF-42785AQP10up-regulateshsa-mir-301repressesR-1923710Drugs (56)
CMF-43248PROKR2up-regulateshsa-mir-30brepressesR-19294Drugs (56)
CMF-43284POLRMTdown-regulateshsa-mir-7repressesR-192187Drugs (56)
CMF-43292POLRMTdown-regulateshsa-mir-17-3prepressesR-192529Drugs (56)
CMF-43336LRFN2up-regulateshsa-mir-30brepressesR-19294Drugs (56)